2604.01953 FEBUX-CV: Transparent Febuxostat Cardiovascular Risk-Context Stratification Before or During Urate-Lowering Therapy
Febuxostat is an important urate-lowering option when allopurinol is not tolerated, contraindicated, or ineffective, but cardiovascular safety remains a real bedside concern in patients with gout and high cardiac comorbidity. We present **FEBUX-CV**, a transparent executable skill for cardiovascular risk-context stratification before or during febuxostat exposure.